I could eat normally again, just way smaller portions
A medication producing 24% weight loss is less valuable than one producing 20% if intolerable side effects cause patients to discontinue treatment
USA 111 , 41154120 (2014)
Exosomes: The link between GPCR activation and metastatic potential
In addition, the high cost of GLP-1 therapies remains a barrier, especially in markets with limited insurance coverage or constrained healthcare budgets The annual cost of treatment with drugs such as Wegovy or Zepbound can exceed several thousand dollars, which may limit accessibility for patients without comprehensive health coverage
Side effects observed in Phase 2 studies include nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions